Autoimmune regulation of prostate cancer by annexin a3

Details Autoimmune regulation of prostate cancer by annexin a3 Autoimmune regulation of prostate cancer by annexin a3

G - Physics

01

N

G01N 33/574 (2006.01)

Patent

CA 2682899

The present invention relates to a method for the diagnosis of prostate carcinoma comprising the determination of annexin A3 (ANXA3) and/or autoantibodies against ANXA3 with a specific reagent. The method allows differentiation between benign, premalignant and malignant conditions. Further, the method has a prognostic relevance.

La présente invention concerne un procédé permettant de diagnostiquer le carcinome de la prostate comprenant la détermination de l'annexine A3 (ANXA3) et/ou des auto-anticorps contre ANXA3 au moyen d'un réactif spécifique. Le procédé permet de faire la différence entre des conditions bénignes, prémalignes et malignes. En outre, le procédé présente un intérêt pronostique.

Affiliated with

Also associated with

Rating

Autoimmune regulation of prostate cancer by annexin a3 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Autoimmune regulation of prostate cancer by annexin a3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Autoimmune regulation of prostate cancer by annexin a3 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1480144